MOL-376

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameMOL-376
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThrombin inhibitors
TargetsProthrombin
Therapy Area/IndicationsVenous ThrombosisAngina, Unstable
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecumetics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecumetics Ltd
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisAngina, Unstable

Other Information

ATC CodeN/A
Related LinksN/A